Summit Trail Advisors’s Alaunos Therapeutics TCRT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-169
| Closed | -$1.79K | – | 636 |
|
|
2023
Q4 | $1.79K | Hold |
169
| – | – | ﹤0.01% | 559 |
|
|
2023
Q3 | $3.35K | Hold |
169
| – | – | ﹤0.01% | 547 |
|
|
2023
Q2 | $12.9K | Buy |
+169
| New | +$12.9K | ﹤0.01% | 541 |
|
|
2023
Q1 | – | Sell |
-169
| Closed | -$16.5K | – | 436 |
|
|
2022
Q4 | $16.5K | Hold |
169
| – | – | ﹤0.01% | 402 |
|
|
2022
Q3 | $44K | Hold |
169
| – | – | ﹤0.01% | 371 |
|
|
2022
Q2 | $31K | Sell |
169
-16
| -9% | -$2.94K | ﹤0.01% | 380 |
|
|
2022
Q1 | $18K | Hold |
185
| – | – | ﹤0.01% | 325 |
|
|
2021
Q4 | $30K | Hold |
185
| – | – | ﹤0.01% | 293 |
|
|
2021
Q3 | $51K | Buy |
+185
| New | +$51K | ﹤0.01% | 261 |
|
|
2019
Q1 | – | Sell |
-185
| Closed | -$52K | – | 128 |
|
|
2018
Q4 | $52K | Hold |
185
| – | – | 0.02% | 104 |
|
|
2018
Q3 | $89K | Hold |
185
| – | – | 0.02% | 275 |
|
|
2018
Q2 | $84K | Hold |
185
| – | – | 0.03% | 232 |
|
|
2018
Q1 | $125K | Hold |
185
| – | – | 0.02% | 392 |
|
|
2017
Q4 | $128K | Buy |
+185
| New | +$128K | 0.02% | 560 |
|